Regenyx Medical is redefining minimally invasive soft tissue restoration—a cornerstone of plastic and reconstructive surgery.

Our lead product, Lipogenyx, is the first fat viability extender: a next-generation fat grafting solution that enhances graft survival and integration, enabling natural-looking, lasting and predictable results in reconstructive and aesthetic procedures.

Built on a proprietary synthetic peptide hydrogel technology, Lipogenyx offers a scalable, potentially reimbursable platform that eliminates the need to revision fat grafting procedures and streamlines physicians efficiency and patient satisfaction.

Selected for the 2025 MedTech Innovator and ASPS Top 5 Innovation Track, Regenyx is now preparing for its first clinical study and establishing U.S. operations.